Innovating Works

STEMTEK THERAPEUTICS

Extinguida
3DCC: Ready to use 3D Cell Cultures for early de risking in drug development STEMTEK THERAPEUTICS tramitó un H2020: H2020-SMEInst-2016-2017 StemTek is a global biopharmaceutical company with a clear stem cell focus in drug development for cancer treatment. Only about 10% of the c...
2016-12-07 - 2017-04-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.